Matches in Wikidata for { <http://www.wikidata.org/entity/Q90224620> ?p ?o ?g. }
- Q90224620 description "artículu científicu espublizáu en payares de 2018" @default.
- Q90224620 description "scientific article published on 30 November 2018" @default.
- Q90224620 description "wetenschappelijk artikel" @default.
- Q90224620 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q90224620 name "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 name "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 type Item @default.
- Q90224620 label "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 label "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 prefLabel "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 prefLabel "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 P1433 Q90224620-69948ACD-F4F3-4AF7-B092-3C59BAFBEC1C @default.
- Q90224620 P1476 Q90224620-8519C41B-2CE5-4AF4-AEC5-C1A685A2A2CF @default.
- Q90224620 P2093 Q90224620-25A48063-503A-427A-AB0B-92AD321F696C @default.
- Q90224620 P2093 Q90224620-5AB08149-C7F0-4187-AA6C-5FC9C41A0198 @default.
- Q90224620 P2093 Q90224620-7418D586-B02D-4863-8DC6-49236AD2C342 @default.
- Q90224620 P2093 Q90224620-8507F941-98EA-4582-9EB1-DB045C2E9439 @default.
- Q90224620 P2093 Q90224620-885C7BDB-F63E-4BB8-8F21-AD8AE72D8BA0 @default.
- Q90224620 P2093 Q90224620-8B5465D4-5887-4411-B7CF-E19AD79EF144 @default.
- Q90224620 P2093 Q90224620-AAF10102-0E87-4B31-846C-E089798F1E17 @default.
- Q90224620 P2093 Q90224620-C4178A1A-C7DD-45E2-909E-BEBA2F3135F5 @default.
- Q90224620 P2093 Q90224620-C92539F1-ABA9-41B2-BA07-A7CD3962C1C5 @default.
- Q90224620 P2093 Q90224620-F9D7CEC8-1B5F-447C-9C4D-EA97F6A2C145 @default.
- Q90224620 P2860 Q90224620-0D479DB4-0DA7-48EC-B03E-563E6939E659 @default.
- Q90224620 P2860 Q90224620-0E0F997C-2566-40E6-942F-E3E3ECBDA755 @default.
- Q90224620 P2860 Q90224620-1C303AE5-F4FF-4ED0-8E27-4948EB85E151 @default.
- Q90224620 P2860 Q90224620-2C52C668-DE28-45EA-9B19-9B709F85B009 @default.
- Q90224620 P2860 Q90224620-2EF3458B-D065-4B8B-8B96-F129FFBE2FE5 @default.
- Q90224620 P2860 Q90224620-3F09A6DA-5741-4260-9C44-795178BE9334 @default.
- Q90224620 P2860 Q90224620-4F732814-E4BF-49A7-8883-AEB5F80A9401 @default.
- Q90224620 P2860 Q90224620-5AFB2EB5-8DCF-4AF9-A4D6-8E48DD88A68E @default.
- Q90224620 P2860 Q90224620-5E54F1E1-7BB8-47B6-98A2-0E37877C8330 @default.
- Q90224620 P2860 Q90224620-684B9DFA-1F04-4A19-813E-59D64C2048DF @default.
- Q90224620 P2860 Q90224620-6B2253FD-4011-4C8F-87A4-8AAD7FB46473 @default.
- Q90224620 P2860 Q90224620-7D0E8934-6192-440B-A1D9-79ABD46E222A @default.
- Q90224620 P2860 Q90224620-894FEB69-119F-4F14-9219-06ED85370AE7 @default.
- Q90224620 P2860 Q90224620-8D4A686C-5ECC-4DE0-B29D-0ACC1539027B @default.
- Q90224620 P2860 Q90224620-98167BB5-797C-4E76-8DE2-5AFFFCA7CFA2 @default.
- Q90224620 P2860 Q90224620-A06F628A-D853-4A3F-A74B-CE5E3F9376A7 @default.
- Q90224620 P2860 Q90224620-ADCDB521-5968-4BF1-8B22-5F7378919739 @default.
- Q90224620 P2860 Q90224620-D25594FC-7493-438A-942B-DE37F7435129 @default.
- Q90224620 P2860 Q90224620-DCD78D70-C9F1-4694-983B-8DAB93E72F5E @default.
- Q90224620 P2860 Q90224620-DCD8C282-9948-4771-9A7D-0CF02900BC7E @default.
- Q90224620 P2860 Q90224620-E41925F2-F516-479F-A582-695763F0302F @default.
- Q90224620 P2860 Q90224620-E5B16C68-2EDD-4289-8B18-969096F61678 @default.
- Q90224620 P2860 Q90224620-E83A02C6-7CD0-4EA9-A07A-7004528FB0CE @default.
- Q90224620 P2860 Q90224620-FC694A00-56A2-4616-8E94-A77AEE3333F2 @default.
- Q90224620 P304 Q90224620-5CA0C06B-36B5-4101-B319-57E8A20E3284 @default.
- Q90224620 P31 Q90224620-839D7AB4-030B-4BD6-BE0B-1FAD5CCCED14 @default.
- Q90224620 P356 Q90224620-36B61C08-9C56-4E9C-85A7-47B56635B40F @default.
- Q90224620 P433 Q90224620-712610CB-7BC1-4433-A2D3-472EB431F583 @default.
- Q90224620 P478 Q90224620-41BD72DC-5688-4A55-821B-83E0F28C91BE @default.
- Q90224620 P50 Q90224620-097EABDA-BE1A-406B-BB67-B11801EF40DB @default.
- Q90224620 P50 Q90224620-0BDA05D8-974E-4D8E-8AA4-9C0C54443BB9 @default.
- Q90224620 P50 Q90224620-11BE14EF-3D20-4ED1-9DB2-3FBC890910E1 @default.
- Q90224620 P50 Q90224620-30FC470E-628B-48B1-B540-84A0E7C4066E @default.
- Q90224620 P50 Q90224620-7A88935F-D458-4769-93A8-3D04C6EE8C2A @default.
- Q90224620 P50 Q90224620-A1D2F302-E2F2-4677-8BED-B70D5AD0DECA @default.
- Q90224620 P50 Q90224620-EAEF96C4-A5C6-4FFE-A0F7-77A41B0DB170 @default.
- Q90224620 P577 Q90224620-D412A289-6F8E-40E3-BD5D-48578482B8EB @default.
- Q90224620 P698 Q90224620-CBF856C7-2D74-47C9-BDD5-286FE414EBFF @default.
- Q90224620 P921 Q90224620-0D2C7DD9-2CA2-44A5-A733-7CFC3076AA7A @default.
- Q90224620 P921 Q90224620-47457613-6E49-465B-BA8C-777669EB223F @default.
- Q90224620 P921 Q90224620-8820B17F-5C1A-4FC0-9A72-5BB575FB195F @default.
- Q90224620 P921 Q90224620-9CE4AF3D-CB00-492A-8244-A7434C236B02 @default.
- Q90224620 P921 Q90224620-AC1F6DC0-239F-4380-94D7-A3017B01033D @default.
- Q90224620 P356 S0140-6736(18)31999-8 @default.
- Q90224620 P698 30509740 @default.
- Q90224620 P1433 Q939416 @default.
- Q90224620 P1476 "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study" @default.
- Q90224620 P2093 "Ainara Soria" @default.
- Q90224620 P2093 "Christophe Le Tourneau" @default.
- Q90224620 P2093 "Jean-Pascal Machiels" @default.
- Q90224620 P2093 "Jonathan Cheng" @default.
- Q90224620 P2093 "José Dinis" @default.
- Q90224620 P2093 "KEYNOTE-040 investigators" @default.
- Q90224620 P2093 "Myung-Ju Ahn" @default.
- Q90224620 P2093 "Nicolas Mach" @default.
- Q90224620 P2093 "Pingye Zhang" @default.
- Q90224620 P2093 "Ranee Mehra" @default.
- Q90224620 P2860 Q28131668 @default.
- Q90224620 P2860 Q29616218 @default.
- Q90224620 P2860 Q29619399 @default.
- Q90224620 P2860 Q29620851 @default.
- Q90224620 P2860 Q33381094 @default.
- Q90224620 P2860 Q34193619 @default.
- Q90224620 P2860 Q36729516 @default.
- Q90224620 P2860 Q37488983 @default.
- Q90224620 P2860 Q38849759 @default.
- Q90224620 P2860 Q38959172 @default.
- Q90224620 P2860 Q39190801 @default.
- Q90224620 P2860 Q39193035 @default.
- Q90224620 P2860 Q40163779 @default.
- Q90224620 P2860 Q41316099 @default.
- Q90224620 P2860 Q41501755 @default.
- Q90224620 P2860 Q41979947 @default.
- Q90224620 P2860 Q43164702 @default.
- Q90224620 P2860 Q43974598 @default.
- Q90224620 P2860 Q45040428 @default.
- Q90224620 P2860 Q46863365 @default.